- Home
- WLK vs ASND Comparison
WLK vs ASND Comparison
Compare WLK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLK
- ASND
- Stock Information
- Founded
- WLK 1986
- ASND 2006
- Country
- WLK United States
- ASND Denmark
- Employees
- WLK N/A
- ASND N/A
- Industry
- WLK Major Chemicals
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- WLK Industrials
- ASND Health Care
- Exchange
- WLK Nasdaq
- ASND Nasdaq
- Market Cap
- WLK 10.1B
- ASND 12.2B
- IPO Year
- WLK 2004
- ASND 2015
- Fundamental
- Price
- WLK $63.91
- ASND $200.83
- Analyst Decision
- WLK Buy
- ASND Strong Buy
- Analyst Count
- WLK 16
- ASND 17
- Target Price
- WLK $92.31
- ASND $245.76
- AVG Volume (30 Days)
- WLK 1.2M
- ASND 364.4K
- Earning Date
- WLK 10-30-2025
- ASND 11-12-2025
- Dividend Yield
- WLK 3.25%
- ASND N/A
- EPS Growth
- WLK N/A
- ASND N/A
- EPS
- WLK N/A
- ASND N/A
- Revenue
- WLK $11,480,000,000.00
- ASND $576,332,355.00
- Revenue This Year
- WLK N/A
- ASND $104.98
- Revenue Next Year
- WLK $3.14
- ASND $79.91
- P/E Ratio
- WLK N/A
- ASND N/A
- Revenue Growth
- WLK N/A
- ASND 54.50
- 52 Week Low
- WLK $63.89
- ASND $118.03
- 52 Week High
- WLK $133.51
- ASND $216.45
- Technical
- Relative Strength Index (RSI)
- WLK 27.12
- ASND 48.54
- Support Level
- WLK $63.89
- ASND $195.80
- Resistance Level
- WLK $70.62
- ASND $202.41
- Average True Range (ATR)
- WLK 2.53
- ASND 7.05
- MACD
- WLK -0.78
- ASND -0.90
- Stochastic Oscillator
- WLK 5.77
- ASND 40.82
About WLK Westlake Corporation
Westlake Corp is a manufacturer and supplier of chemicals, polymers, and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.